Skip to content
777 Sourcing.

From the company

Akelos Inc. is an innovative research-based biotechnology/biopharmaceutical clinical company focused on translating innovative science into treatment. It is developing novel non-narcotic (non-opioid) drugs for the treatment of neuropathic pain, with a non-opioid drug candidate in pre-clinical development. Its development efforts focus on the HCN1 ion channel in primary sensory neurons. The company is partially funded by the National Institutes of Health (NIH) and has exclusively licensed intellectual property from Cornell University.

Location: NEW YORK, NY, USFounded: 2018Ownership: Self Certified Small Disadvantaged BusinessCapabilities: 4Facilities: 1

Products & services offered

Classifications
Ownership classifications (1)
Self Certified Small Disadvantaged Business

Facilities

Headquarters

215 E 68TH ST APT 26B, NEW YORK, NY 10065-5729, US

View map

Send your requirements

Quantities, certifications, and timing.

Send your requirements · Supplier responds with a quote · Compare and decide

Similar products and services